Recommendations for chemoprophylaxis after occupational exposure to human immunodeficiency virus: A public health agency perspective

American Journal of Medicine

Volumn 102, Issue 5 B, 1997, Pages 98-101

  Danila, Richard N ^a  

^a MINNESOTA DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; PROTEINASE INHIBITOR; ZIDOVUDINE;

CHEMOPROPHYLAXIS; CONFERENCE PAPER; DRUG EFFICACY; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; OCCUPATIONAL EXPOSURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; UNITED STATES; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; GUIDELINES; GUIDELINES AS TOPIC; HEALTH PERSONNEL; HEALTH POLICY; HIV INFECTIONS; HUMANS; INFECTION CONTROL; MANDATORY TESTING; MINNESOTA; OCCUPATIONAL EXPOSURE; PUBLIC HEALTH ADMINISTRATION; UNITED STATES;

EID: 0030786490     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00074-0     Document Type: Conference Paper

References (10)

1. Institute of Medicine. The Future of Public Health. Washington, DC: National Academy Press, 1988.
2. Centers for Disease Control. Surveillance for occupationally acquired HIV infection - United States, 1981-1992. MMWR. 1992;41:823-825.
3. Centers for Disease Control. Surveillance for occupationally acquired human immunodeficiency virus infection. MMWR. 1992;41:501-502.
4. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. 1995;7(no. 2).
5. Valdiserri RO, Aultman TV, Curran JW. Community planning: a national strategy to improve HIV prevention programs. J Community Health. 1995;20:87-99.
6. Centers for Disease Control and Prevention. Recommendations for the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR. 1994;43(No. RR-11).
7. Centers for Disease Control and Prevention. U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR. 1995;44(No. RR-7).
8. Centers for Disease Control. Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use. MMWR. 1990;39(No. RR-1).
9. Gerberding JL, Littell C, Tarkington A, Brown A, Schecter WP. Risk of exposure of surgical personnel to patients' blood during surgery at San Francisco General Hospital. N Engl J Med. 1990;322:1788-1793.
10. Congress extends Ryan White Act, reaches deal on testing of infants. AIDS Policy and Law. May 17, 1996; Vol. 11, No. 9: 1, 10-11.